{"id":"https://openalex.org/W4402012243","doi":"https://doi.org/10.2147/bctt.s271441","title":"Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer","display_name":"Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer","publication_year":2024,"publication_date":"2024-08-01","ids":{"openalex":"https://openalex.org/W4402012243","doi":"https://doi.org/10.2147/bctt.s271441","pmid":"https://pubmed.ncbi.nlm.nih.gov/39224861","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11368096"},"language":"en","primary_location":{"id":"doi:10.2147/bctt.s271441","doi":"https://doi.org/10.2147/bctt.s271441","is_oa":true,"landing_page_url":"https://doi.org/10.2147/bctt.s271441","pdf_url":"https://www.dovepress.com/article/download/95304","source":{"id":"https://openalex.org/S4210232997","display_name":"Breast Cancer Targets and Therapy","issn_l":"1179-1314","issn":["1179-1314"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer: Targets and Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4402012243"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/article/download/95304","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003436557","display_name":"Kaitlyn O'Keefe","orcid":"https://orcid.org/0009-0005-2217-1278","observed_orcids":["https://orcid.org/0009-0005-2217-1278"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlyn O'Keefe","raw_affiliation_strings":["Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA"],"raw_orcid":"https://orcid.org/0009-0005-2217-1278","affiliations":[{"raw_affiliation_string":"Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA","institution_ids":["https://openalex.org/I4210100342","https://openalex.org/I47251452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080772475","display_name":"Neelam Vijay Desai","orcid":"https://orcid.org/0000-0001-8641-0542","observed_orcids":["https://orcid.org/0000-0001-8641-0542"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neelam Desai","raw_affiliation_strings":["Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA","institution_ids":["https://openalex.org/I4210100342","https://openalex.org/I47251452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022891785","display_name":"Antoinette R. Tan","orcid":"https://orcid.org/0000-0002-7895-7000","observed_orcids":["https://orcid.org/0000-0002-7895-7000"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Antoinette Tan","raw_affiliation_strings":["Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA"],"raw_orcid":"https://orcid.org/0000-0002-7895-7000","affiliations":[{"raw_affiliation_string":"Department of Solid Tumor and Investigational Therapeutics, Atrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC, USA","institution_ids":["https://openalex.org/I4210100342","https://openalex.org/I47251452"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5022891785"],"corresponding_institution_ids":["https://openalex.org/I4210100342","https://openalex.org/I47251452"],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":0.5268,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.50282619,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"Volume 16","issue":null,"first_page":"517","last_page":"527"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":1.0},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9459999799728394},{"id":"https://openalex.org/keywords/adjuvant-endocrine-therapy","display_name":"adjuvant endocrine therapy","score":0.9819999933242798},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9409999847412109},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/high-risk-early-breast-cancer","display_name":"high-risk early breast cancer","score":0.9520000219345093},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.8629999756813049},{"id":"https://openalex.org/keywords/ribociclib","display_name":"ribociclib","score":1.0},{"id":"https://openalex.org/keywords/dosage","display_name":"dosage","score":0.824999988079071},{"id":"https://openalex.org/keywords/side-effect-management","display_name":"side effect management","score":0.8980000019073486},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.9010000228881836},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.8859999775886536}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6269837021827698},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6097540855407715},{"id":"https://openalex.org/C2908728163","wikidata":"https://www.wikidata.org/wiki/Q415271","display_name":"Human Epidermal Growth Factor Receptor 2","level":4,"score":0.5963121652603149},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5494963526725769},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5070533752441406},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.4921390414237976},{"id":"https://openalex.org/C23589133","wikidata":"https://www.wikidata.org/wiki/Q412005","display_name":"Hormone receptor","level":4,"score":0.476483553647995},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4542555809020996},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.43759724497795105},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.43667739629745483},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.43370482325553894},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.39656031131744385},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.38595038652420044},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3627542555332184}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/bctt.s271441","doi":"https://doi.org/10.2147/bctt.s271441","is_oa":true,"landing_page_url":"https://doi.org/10.2147/bctt.s271441","pdf_url":"https://www.dovepress.com/article/download/95304","source":{"id":"https://openalex.org/S4210232997","display_name":"Breast Cancer Targets and Therapy","issn_l":"1179-1314","issn":["1179-1314"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer: Targets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11368096","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11368096","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11368096/pdf/bctt-16-517.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer (Dove Med Press)","raw_type":"Text"},{"id":"pmid:39224861","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39224861","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast cancer (Dove Medical Press)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:be056c6ba056409ea620b5f2995cf652","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/be056c6ba056409ea620b5f2995cf652","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 517-527 (2024)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/95304","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/practical-guidance-on-abemaciclib-in-combination-with-adjuvant-endocri-peer-reviewed-fulltext-article-BCTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/bctt.s271441","doi":"https://doi.org/10.2147/bctt.s271441","is_oa":true,"landing_page_url":"https://doi.org/10.2147/bctt.s271441","pdf_url":"https://www.dovepress.com/article/download/95304","source":{"id":"https://openalex.org/S4210232997","display_name":"Breast Cancer Targets and Therapy","issn_l":"1179-1314","issn":["1179-1314"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","norway-1","oarl","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4402012243.pdf","grobid_xml":"https://content.openalex.org/works/W4402012243.grobid-xml"},"referenced_works_count":64,"referenced_works":["https://openalex.org/W1828378256","https://openalex.org/W1991601194","https://openalex.org/W1998040747","https://openalex.org/W1999130958","https://openalex.org/W1999149570","https://openalex.org/W2073482997","https://openalex.org/W2074918415","https://openalex.org/W2150134401","https://openalex.org/W2159427817","https://openalex.org/W2255638054","https://openalex.org/W2491062142","https://openalex.org/W2528767298","https://openalex.org/W2552099557","https://openalex.org/W2612124029","https://openalex.org/W2617437931","https://openalex.org/W2620993107","https://openalex.org/W2763875663","https://openalex.org/W2767600184","https://openalex.org/W2804105316","https://openalex.org/W2901389151","https://openalex.org/W2910972034","https://openalex.org/W2923271724","https://openalex.org/W2976415870","https://openalex.org/W3081949673","https://openalex.org/W3087501542","https://openalex.org/W3087561595","https://openalex.org/W3097489112","https://openalex.org/W3116128628","https://openalex.org/W3120241209","https://openalex.org/W3148345241","https://openalex.org/W3165576985","https://openalex.org/W3175911175","https://openalex.org/W3206169364","https://openalex.org/W3210269332","https://openalex.org/W4200066800","https://openalex.org/W4206127585","https://openalex.org/W4206939230","https://openalex.org/W4210301377","https://openalex.org/W4211005384","https://openalex.org/W4213418594","https://openalex.org/W4220778872","https://openalex.org/W4220795493","https://openalex.org/W4220955524","https://openalex.org/W4223622943","https://openalex.org/W4225822825","https://openalex.org/W4281809374","https://openalex.org/W4283786358","https://openalex.org/W4304084160","https://openalex.org/W4311018441","https://openalex.org/W4327900078","https://openalex.org/W4367173134","https://openalex.org/W4379191683","https://openalex.org/W4379508645","https://openalex.org/W4379645953","https://openalex.org/W4382193110","https://openalex.org/W4387809691","https://openalex.org/W4389681263","https://openalex.org/W4390706369","https://openalex.org/W4390933149","https://openalex.org/W4390946922","https://openalex.org/W4392977246","https://openalex.org/W4396590741","https://openalex.org/W4396590874","https://openalex.org/W4398133263"],"related_works":["https://openalex.org/W7164762621","https://openalex.org/W4283320931","https://openalex.org/W4211000532","https://openalex.org/W3217553653","https://openalex.org/W3087501542","https://openalex.org/W3211594628","https://openalex.org/W3117963054","https://openalex.org/W2806436530","https://openalex.org/W4210551899","https://openalex.org/W2800554269"],"abstract_inverted_index":{"The":[0,66],"most":[1],"common":[2],"subtype":[3],"of":[4,23,76,100,114,139,163,189,206,232],"breast":[5,18,25,48,78,156,196,217],"cancer":[6,26,79,157,218],"is":[7,59,90,124],"hormone":[8],"receptor":[9,15],"(HR)-positive,":[10],"human":[11],"epidermal":[12],"growth":[13],"factor":[14],"2":[16],"(HER2)-negative":[17],"cancer,":[19],"accounting":[20],"for":[21,44,96,186,212,241],"65-70%":[22],"all":[24],"cases":[27],"diagnosed":[28],"in":[29,62,103,146,150,175,208,222],"the":[30,40,51,74,92,104,112,140,170,180,204],"United":[31],"States.":[32],"Until":[33],"2015,":[34],"single-agent":[35],"endocrine":[36],"therapy":[37,58],"(ET)":[38],"was":[39,169],"recommended":[41,61],"first-line":[42,94],"treatment":[43,75,95,110,188],"metastatic":[45,97,105],"HR-positive,":[46,154,192,213],"HER2-negative":[47,155],"cancer.":[49,197],"However,":[50],"paradigm":[52],"has":[53,143],"since":[54],"shifted,":[55],"as":[56],"targeted":[57],"now":[60,91],"combination":[63,113,147,176,209],"with":[64,88,111,126,148,152,177,191,210],"ET.":[65],"cyclin-dependent":[67],"kinase":[68],"(CDK)":[69],"4/6":[70],"inhibitors":[71,142],"have":[72,107],"revolutionized":[73],"this":[77],"subtype,":[80],"and":[81,118,133,183,226,238,243],"combining":[82],"either":[83],"palbociclib,":[84],"ribociclib,":[85],"or":[86],"abemaciclib":[87,168,207],"ET":[89,119,122,149,178,211],"standard":[93],"disease.":[98],"Results":[99],"clinical":[101],"trials":[102],"setting":[106],"demonstrated":[108],"that":[109],"a":[115],"CDK4/6":[116,141,172],"inhibitor":[117,173],"rather":[120],"than":[121],"alone":[123],"associated":[125],"longer":[127,130],"overall":[128],"survival,":[129,132],"progression-free":[131],"better":[134],"objective":[135],"response":[136],"rates.":[137],"Each":[138],"been":[144],"investigated":[145],"patients":[151,190],"early-stage":[153],"who":[158],"are":[159],"at":[160],"high":[161],"risk":[162],"relapse.":[164],"In":[165],"October":[166],"2021,":[167],"first":[171],"approved":[174],"by":[179],"US":[181],"Food":[182],"Drug":[184],"Administration":[185],"adjuvant":[187],"HER2-negative,":[193,214],"high-risk":[194,215],"early":[195,216],"Herein,":[198],"we":[199,227],"provide":[200],"practical":[201],"guidance":[202],"on":[203],"use":[205],"to":[219],"assist":[220],"clinicians":[221],"their":[223],"day-to-day":[224],"practice,":[225],"review":[228],"clinically":[229],"relevant":[230],"topics":[231],"dosing,":[233],"side":[234],"effect":[235],"management,":[236],"sequencing":[237],"optimal":[239],"timing":[240],"initiation,":[242],"patient":[244],"selection.":[245]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2024-08-30T00:00:00"}
